Trial intelligence / Profile preview

Tissue velocity imaging to predict atrial fibrillation rhythm-control outcome

NL-OMON36728Active, not recruiting

Sponsor
Maastricht University Medical Center+
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Trial of flecainide, ibutilide and amiodarone, sponsored by Maastricht University Medical Center+. Started May 2011; status: active, not recruiting.

02

Drugs

flecainideibutilideamiodarone

Beyond the preview

Go deeper on NL-OMON36728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call